HR 2427 · 108th Congress 2003–2005, ended

Pharmaceutical Market Access Act of 2003

Latest action · Jul 25, 2003 Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Progress

Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.

  1. IntroducedJun 11, 2003
  2. Passed HouseJul 25, 2003
  3. Passed SenateNot reached
  4. To the PresidentNot reached
  5. Became lawNot reached

Summary

(This measure has not been amended since it was introduced. The summary has been expanded because action occurred on the measure.)

Pharmaceutical Market Access Act of 2003 - (Sec. 4) Amends the Federal Food, Drug and Cosmetic Act to direct the Secretary of Health and Human Services to promulgate regulations allowing qualifying individuals to import covered products (in addition to pharmacists and wholesalers, whom current law authorizes to import such products).

Amends provision pertaining to record keeping regarding imported covered products. States that the Secretary shall not have to store records in cases in which qualifying individuals have imported a covered product.

Amends provisions regarding the importation of covered products, including to remove language directing the Secretary to require that a foreign seller specify the original source of the product and the amount of each lot of the product originally received.

Amends provisions regarding the testing of imported covered products. Declares that specified tests, including ones involving authenticity and degradation of products, shall not be required unless the importer is a wholesaler. Requires such tests to be conducted by the importer unless a product is a prescription drug subject to the provisions of this Act pertaining to counterfeit-resistant packaging. (Currently either the importer or the manufacturer may conduct such tests).

Eliminates the sunset date current law establishes for the provisions pertaining to the importation of covered products.

(Sec. 5) Classifies prescription drugs as misbranded if they do not incorporate specified counterfeit-resistant technologies in packaging.

Recorded votes 1

Newest first. Open one to see how every member voted.

Roll callQuestionResultDate
House 445Passed243–186Jul 25, 2003

Cosponsors 53

Members who signed on, in the order they did. Signatures ran from Jun 11, 2003 to Jul 23, 2003; 26 are original cosponsors, there from the day it was introduced.

SeatCosponsorSigned on
R-KYAnne M. NorthupOriginalJun 11, 2003
D-MABarney FrankOriginalJun 11, 2003
R-NCCharles H. TaylorOriginalJun 11, 2003
R-CTChristopher ShaysOriginalJun 11, 2003
D-MNCollin C. PetersonOriginalJun 11, 2003
R-INDan BurtonOriginalJun 11, 2003
R-CADana RohrabacherOriginalJun 11, 2003
R-MTDenny RehbergOriginalJun 11, 2003
R-NEDoug BereuterOriginalJun 11, 2003
R-OKErnest J. Istook Jr.OriginalJun 11, 2003
R-SCHenry E. Brown, Jr.OriginalJun 11, 2003
R-GAJack KingstonOriginalJun 11, 2003
R-TXJeb HensarlingOriginalJun 11, 2003
R-MNJim RamstadOriginalJun 11, 2003
R-MOJo Ann EmersonOriginalJun 11, 2003

Committees 2

Where it was sent and what each committee and subcommittee did with it, in order.

ChamberCommitteeWhat it did
HouseEnergy and Commerce Committee
Referred Jun 11, 2003
Health Subcommittee
Referred Jun 24, 2003
SenateHealth, Education, Labor, and Pensions Committee
Referred Jul 25, 2003

Actions 15

Everything that happened, newest first.

  1. Jul 25, 2003Considered under the provisions of rule H. Res. 335. (consideration: CR H7595-7611)
  2. Jul 25, 2003Rule provides for consideration of H.R. 2427.
  3. Jul 25, 2003DEBATE - The House proceeded with one hour of debate on H.R. 2427.
  4. Jul 25, 2003The previous question was ordered pursuant to the rule.
  5. Jul 25, 2003Mr. Dingell moved to recommit to Energy and Commerce. (consideration: CR H7610; text: CR H7595-7596)

In the Congressional Record 13

Days the Record’s own index lists this bill, newest first, with the pages and the members it names. Pages starting H are the House, S the Senate, E Extensions of Remarks.

WhereIn the RecordMembersDate
HouseDebate and remarks H5168Rahm Emanuel D-ILJul 6, 2004
HouseDebate and remarks H9465Advertisements H9466Gil Gutknecht R-MNOct 15, 2003
HouseDebate and remarks H8261Rahm Emanuel D-ILSep 16, 2003
HouseDebate and remarks H7813Rahm Emanuel D-ILSep 3, 2003
ExtensionsDebate and remarks E1617, E1621, E1622, E1642, E1647, E1648, E1658, E1659Bart Stupak D-MI, Bob Etheridge D-NC, Carolyn B. Maloney D-NY, Carolyn McCarthy D-NY, James A. Leach R-IA, Jerry F. Costello D-IL, Nick Smith R-MI, Walter B. Jones R-NCJul 25, 2003

Research

What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.

Congressional Budget Office cost estimates 2

  1. Nov 19, 2003H.R. 2427, Pharmaceutical Market Access Act of 2003<p>Cost estimate for the bill as passed by the U.S. House of Representatives on July 25, 2003</p>
  2. Nov 19, 2003H.R. 2427, Pharmaceutical Market Access Act of 2003Cost estimate for the bill as passed by the U.S. House of Representatives on July 25, 2003

Printed hearings 3

Hearings whose printed record names this bill, newest first: hearings on it, and wider hearings where it came up.

NumberHearingCommitteeHeld
S. Hrg. 108-923EXAMINING THE IMPLICATIONS OF DRUG IMPORTATION282 pagesJudiciary CommitteeJul 14, 2004
S. Hrg. 108-470IMPORTATION OF PRESCRIPTION DRUGS129 pagesHealth, Education, Labor, and Pensions CommitteeMay 20, 2004
S. Hrg. 108-1011PRESCRIPTION DRUG REIMPORTATION123 pagesCommerce, Science, and Transportation CommitteeNov 20, 2003

CRS reports 1

Congressional Research Service work that CRS links to this bill or the law it became, newest first.

Cite it 1

Products on other subjects that cite it, usually among other measures.

ProductTitleKindPublished
RS22660Prescription Drug Importation: How S. 1232 (S. 525/H.R. 1298) Would Change Current Law ArchivedReportJun 16, 2009

Related bills 3

Companion bills and other measures the record links to this one.

Titles 4

Every title it has carried, official and short, at each stage.

Official Title as Introduced
To authorize the Secretary of Health and Human Services to promulgate regulations for the reimportation of prescription drugs, and for other purposes.
Short Titles as Introduced
Pharmaceutical Market Access Act of 2003
Short Titles as Passed House
Pharmaceutical Market Access Act of 2003
Popular Titles
Imports of Prescription Drugs bill

Subjects

Assigned by the Library of Congress. Policy area: Health.

Text 3

Each version as it was printed, newest first.

  1. Jul 25, 2003Referred in Senate
  2. Jul 25, 2003Engrossed in House
  3. Jun 11, 2003Introduced in House

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details.

Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.